The AI automatically turns a raw CT scan into a precise 3D bone model and identifies key anatomical landmarks, so surgeons get a ready-made surgical blueprint instead of spending hours doing it manually.

Mango Medical's core engineering pipeline ingests raw DICOM CT scan data and applies deep learning-based 3D segmentation models (likely nnU-Net, 3D U-Net, or transformer-based architectures such as Swin-UNETR) to automatically delineate bone surfaces, joint margins, and critical anatomical landmarks. The system generates high-fidelity 3D mesh reconstructions of patient anatomy using mesh deformation networks and point cloud processing, enabling precise virtual templating of implant components. This eliminates the traditional workflow where radiologists and surgeons manually trace anatomical boundaries slice-by-slice, reducing planning time from hours to seconds. The models are trained on proprietary datasets likely enriched through the 8-figure partnership with a major orthopedic company, creating a data flywheel that continuously improves segmentation accuracy across diverse patient anatomies, bone quality variations, and pathological deformities. Transfer learning and domain adaptation techniques allow the platform to generalize from shoulder to hip and knee joints with minimal additional labeled data.

It's like having a master sculptor who can look at a block of marble (your CT scan) and instantly see the statue inside it — except this sculptor also tells the surgeon exactly which chisel to use and where to cut.

The AI acts like a virtual surgical resident that studies the patient's bone structure and automatically recommends the best implant and exactly where to place it, so the surgeon can review and approve rather than build the plan from scratch.

Mango Medical's product differentiator is its agentic planning layer — a multi-step AI pipeline that goes beyond passive segmentation to actively reason about surgical strategy. After generating a 3D anatomical model, the system autonomously evaluates thousands of implant configurations (size, position, orientation, offset) against biomechanical constraints, bone quality maps, and patient-specific anatomical parameters. This likely involves a combination of reinforcement learning or optimization algorithms that simulate surgical outcomes, multi-task encoder-decoder networks that jointly predict optimal component placement, and constraint satisfaction solvers that enforce manufacturer specifications and clinical best practices. The agentic framework may also incorporate vision-language model capabilities to interpret surgeon preferences expressed in natural language (e.g., "maximize range of motion" or "prioritize bone preservation") and translate them into quantitative planning parameters. The 8-figure LOI from a major orthopedic company likely includes integration with that manufacturer's implant catalog, giving the system access to precise CAD models and placement guidelines that enable highly accurate virtual templating. This closed-loop between implant manufacturer data and AI planning creates a powerful moat.

It's like having a master tailor who doesn't just measure you — they also pick the perfect fabric, cut the pattern, and pin everything in place before you even sit down for a fitting.

The AI predicts how well a patient's joint will function after surgery and flags potential complications before the operation even happens, helping surgeons pick the safest and most effective plan.

Beyond planning the surgery itself, Mango Medical's data science capabilities likely extend to predictive outcome modeling — using machine learning to forecast post-operative biomechanical performance, implant longevity, and complication risk for each candidate surgical plan. By training on longitudinal datasets that link preoperative CT features, surgical plan parameters, and post-operative outcomes (range of motion, revision rates, patient-reported scores), the platform can build gradient-boosted ensemble models or deep survival networks that estimate the probability of specific adverse events (implant loosening, periprosthetic fracture, dislocation) for each proposed plan. This transforms the planning tool from a static recommendation engine into a dynamic decision-support system where surgeons can compare multiple plan options side-by-side with quantified risk-benefit tradeoffs. The 8-figure partnership with a major orthopedic company likely provides access to implant registry data and post-market surveillance datasets that are essential for training these predictive models — a data asset that would be nearly impossible for competitors to replicate independently. Over time, this outcome prediction layer creates a powerful feedback loop: as more surgeries are planned and tracked through the platform, the models become increasingly accurate, deepening the moat.

It's like a weather forecast for your surgery — instead of just telling you to bring an umbrella, it shows you exactly which route has the least chance of rain and the smoothest road.